Danapha Pharmaceutical JSC (HSTC:DAN) Research & Development: ₫ Mil (TTM As of . 20)


HSTC:DAN Danapha Pharmaceutical JSC HSTC:DAN
30 GF Score
Price ₫30,300.00
! 1 Warning Sign
View Full Analysis

What is Danapha Pharmaceutical JSC Research & Development?

Danapha Pharmaceutical JSC HSTC:DAN 30 Research & Development is ₫ Mil as of . 20. GuruFocus rates HSTC:DAN with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Danapha Pharmaceutical JSC's Research & Development for the six months ended in . 20 was ₫0.00 Mil. Danapha Pharmaceutical JSC does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Danapha Pharmaceutical JSC  (HSTC:DAN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Danapha Pharmaceutical JSC Research & Development Related Terms

Danapha Pharmaceutical JSC Research & Development Historical Data

* Premium members only.

The historical data trend for Danapha Pharmaceutical JSC's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danapha Pharmaceutical JSC Research & Development Chart

Danapha Pharmaceutical JSC Annual Data
Trend
Research & Development

Danapha Pharmaceutical JSC Semi-Annual Data
Research & Development
HSTC:DAN
30GF Score
Danapha Pharmaceutical JSC HSTC:DAN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Danapha Pharmaceutical JSC Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₫ Mil mean?
Danapha Pharmaceutical JSC (HSTC:DAN) has a Research & Development of ₫ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Danapha Pharmaceutical JSC and its competitors.
Is Danapha Pharmaceutical JSC's Research & Development too high?
Danapha Pharmaceutical JSC's current Research & Development is ₫ Mil. Overall, Danapha Pharmaceutical JSC has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Danapha Pharmaceutical JSC's Research & Development compare to ZTS and UTHR?
Danapha Pharmaceutical JSC's Research & Development of ₫ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Danapha Pharmaceutical JSC and its competitors. Danapha Pharmaceutical JSC's current Research & Development is ₫ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danapha Pharmaceutical JSC stock overvalued right now?
Danapha Pharmaceutical JSC (HSTC:DAN) has a current Research & Development of ₫ Mil. The current Research & Development is ₫ Mil. Danapha Pharmaceutical JSC's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Danapha Pharmaceutical JSC (HSTC:DAN), the current Research & Development is ₫ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Danapha Pharmaceutical JSC Business Description

Address 253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.
30GF Score

Get the complete analysis for HSTC:DAN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫30,300.00
Price